BreathDX

BreathDX (UK) Ltd. is a technology company built to lead the charge in the surging market of breath analysis and diagnosis. Human breath contains a wealth of analytes and thus data to measure health, disease progression and potential threats to future wellbeing. Breath is a non-invasive alternative to blood testing. The key task is to unlock this data by measuring analytes, often at minute concentrations within the heat and moisture of our breath.

 

Ammonia is a very important chemical in breath that is linked with a range of known and likely conditions. Accurately and easily detecting ammonia in breath is essential for doctors making clinical decisions, patients living with conditions or those researching the many processes involving the metabolism of ammonia. Existing ammonia breath diagnostic solutions are typically specific to diseases, complicated, have a high cost and are not suited to point-of-care or high-volume testing.

 

BreathDX's patented and patent-pending AmBeR® device is a flexible-cost, clinically relevant solution, ideal for point-of-care use. AmBeR® will address a broad range of market opportunities in which ammonia measurement and monitoring is required.